9 December 2022
-
Arthrex launches minimally invasive procedure for bunion correction with less pain and downtime
USA — Arthrex, a provider of minimally invasive orthopedic technology, has launched the Arthrex Minimally Invasive Bunionectomy System to offer patients a solution to traditional…
-
Aspen urges ViiV to licence injectable HIV drugs to African generic manufacturers
SOUTH AFRICA – Medicines manufacturer Aspen Pharmacare recommends that African companies be given licenses to manufacture HIV prevention drugs so as to be more accessible…
-
Kisumu County launches primary health care strategy focusing on preventive care
KENYA – Kisumu County Government has developed a primary health care strategy that shifts much focus to preventive care with partners calling for more allocation…
-
DCGI approves India’s first Ebola vaccine for export to Uganda, first shipment arrives
UGANDA – India’s first Ebola vaccine has been approved by the Drugs Controller General of India (DCGI) for export to Uganda. The vaccine has been…
-
Blackstone’s hunt for first hospital deal brings it one-on-one with India’s Care Hospitals
INDIA —Blackstone, the world’s largest private equity group, is the one contender left within the race to acquire Care Hospitals for 7,800-8,000 crore (US$947.5 –…
-
NICD declares measles outbreak in North-West and Gauteng provinces of South Africa
SOUTH AFRICA – The National Institute for Communicable Diseases (NICD) has declared a measles outbreak in the North-West and Gauteng after both provinces reported three…
-
Four African hospitals receive accreditation awards from COHSASA
SOUTH AFRICA – The Council for Health Service Accreditation of Southern Africa (COHSASA), a not-for-profit company (NPC) based in Cape Town has awarded accreditation to…
-
COVID disruption resulted in 63,000 more malaria deaths—WHO
SWITZERLAND — The coronavirus pandemic interrupted efforts to control malaria, resulting in 63,000 additional deaths and 13 million more infections globally over two years, according…
-
Takeda’s dengue vaccine bags EU approval, opening door for wider global use
BELGIUM—Takeda Pharmaceutical’s dengue vaccine has been authorized for use in the European Union, making it the second approved inoculation against the mosquito-borne disease that causes…
-
Pfizer’s RSV vaccine gets priority review from the FDA, decision expected May 2023
USA — Pfizer, in a statement, said the FDA has accepted its RSV vaccine candidate for review under an expedited process that reduces the approval…